# OnCo record nct05186753 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct05186753/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct05186753", "NCT05186753" ;
  schema:name "(Summit) A Study to Evaluate the Efficacy and Safety of CGT9486 Versus Placebo in Patients With Indolent or Smoldering Systemic Mastocytosis"@en ;
  schema:description "A phase 2 trial of Bezuclastinib in systemic mastocytosis, run by Cogent Biosciences, Inc., active and no longer recruiting."@en ;
  schema:url <https://onco.cc/trials/nct05186753/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT05186753> ;
  onco:status "active" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "2" ;
  schema:startDate "2022-06-27" ;
  onco:cancers <https://onco.cc/cancers/systemic-mastocytosis/>, <https://onco.cc/cancers/indolent-systemic-mastocytosis/> ;
  onco:drugs <https://onco.cc/drugs/bezuclastinib/> ;
  onco:companies <https://onco.cc/companies/cogent-biosciences/> .